Abstract

Ultrasound imaging has long demonstrated utility in the study and measurement of anatomic features and noninvasive observation of blood flow. Within the last decade, advances in molecular biology and contrast agents have allowed researchers to use ultrasound to detect changes in the expression of molecular markers on the vascular endothelium and other intravascular targets. This new technology, referred to as ultrasonic molecular imaging, is still in its infancy. However, in preclinical studies, ultrasonic molecular imaging has shown promise in assessing angiogenesis, inflammation, and thrombus. In this review, we discuss recent advances in microbubble-type contrast agent development, ultrasound technology, and signal processing strategies that have the potential to substantially improve the capabilities and utility of ultrasonic molecular imaging.

Highlights

  • Contrast AgentsThe fundamental enabling technology for ultrasonic molecular imaging is the contrast agent

  • Ultrasound imaging has long demonstrated utility in the study and measurement of anatomic features and noninvasive observation of blood flow

  • Standard ultrasound imaging is well suited for assessment of anatomic features and measurement of blood flow in large vessels; there is no mechanism by which non– contrast-enhanced ultrasound can detect changes in physiology on a molecular level

Read more

Summary

Contrast Agents

The fundamental enabling technology for ultrasonic molecular imaging is the contrast agent. Contrast agents for ultrasound imaging include microbubbles,[1,2,3,4,5,6] echogenic liposomes,[7,8,9] perfluorocarbon droplets,[10,11,12] and other materials such as gold particles,[13] which have a density and compressibility substantially different from that of blood and tissue. It is for this reason that encapsulated microbubbles are the most prevalent form of contrast agent, and they are currently the only type of ultrasound contrast agent approved for clinical use in the United

Gessner and Dayton
Ultrasound Molecular Imaging
Challenges in Molecular Imaging with Ultrasound
Low Numbers of Retained Contrast Agents
High Background from Freely Circulating Agents
Limited Field of View
Quantitative Ability
Possible Immune Responses
Imaging and Detection Technology
Improvements in Microbubble Delivery
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.